exactly, especially when Gilead pays $21 billion f
Post# of 148147
(Total Views: 627)
Posted On: 07/21/2022 8:09:30 PM
Re: humble howard #126701
exactly, especially when Gilead pays $21 billion for trodelvy alone and when GSK already spent $5.1 billion for dolstarlimab alone.
This CCR5 binder/blocker does everything those do and 50x more. CCR5 blockade makes Leronlimab the perfect molecule to pair with, especially since Leronlimab has no black box warnings and no ASE.
This CCR5 binder/blocker does everything those do and 50x more. CCR5 blockade makes Leronlimab the perfect molecule to pair with, especially since Leronlimab has no black box warnings and no ASE.
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼